Mangoceuticals Ratios (2023-2025) | MGRX

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 56.79%61.69%58.98%58.35%68.85%42.77%61.99%76.11%56.78%53.51%60.42%
EBT Margin -2,542.53%-1,617.16%-733.99%-1,050.87%-1,105.87%-1,465.60%-1,499.38%-1,851.45%-4,427.47%-3,221.61%-9,043.49%
EBIT Margin -2,540.78%-1,622.99%-733.99%-1,050.87%-1,105.87%-1,329.13%-1,318.21%-1,594.02%-4,440.00%-3,133.98%-8,953.45%
EBITDA Margin -2,540.78%-1,622.99%-733.99%-1,050.87%-1,105.87%-1,329.13%-1,318.21%-1,594.02%-4,440.00%-3,133.98%-8,953.45%
Operating Margin -2,540.78%-1,622.99%-733.99%-1,050.87%-1,105.87%-1,329.13%-1,318.21%-1,594.02%-4,440.00%-3,133.98%-8,953.45%
Net Margin -2,542.53%-1,617.16%-733.99%-1,050.87%-1,105.87%-1,465.60%-1,719.48%-1,851.45%-4,427.47%-3,221.61%-9,391.80%
FCF Margin -1,798.83%-1,260.71%-697.81%-694.73%-462.94%-966.66%-874.15%-1,073.26%-2,081.11%-747.40%-1,473.38%
Efficiency
Inventory Average 0.02M0.02M0.02M0.01M0.01M-0.00M
Assets Average 2.45M1.32M0.68M7.77M15.01M15.08M18.56M21.30M18.69M
Equity Average 2.18M1.06M-0.09M6.44M13.61M13.67M17.10M19.75M17.49M
Invested Capital 3.00M1.35M0.77M-0.96M13.83M13.39M13.95M20.25M19.24M15.73M
Asset Utilization Ratio 0.551.250.110.050.040.030.020.02
Leverage & Solvency
Interest Coverage Ratio 354.25-242.79-99.45
Equity Ratio 0.910.850.74-3.180.910.910.910.930.920.95
Times Interest Earned 354.25-242.79-99.45
Valuation
Enterprise Value -2.95M-1.24M-0.76M-0.02M-0.49M-0.09M-0.08M-0.09M-0.12M-0.50M
Return Ratios
Return on Sales -25.43%-16.17%-7.34%-10.51%-11.06%-14.66%-14.99%-18.51%-44.27%-32.22%-90.43%
Return on Capital Employed -8.29%16.84%-1.39%-0.65%-0.58%-0.61%-0.69%-1.08%
Return on Assets -6.96%-13.34%-1.17%-0.62%-0.58%-0.60%-0.67%-1.06%
Return on Equity -8.65%98.19%-1.42%-0.69%-0.64%-0.65%-0.72%-1.13%